Peer Exchange

Collaborative Approach in Managing HIV Treatment Costs
March 26, 2018 – 
Peter L. Salgo, MD; Michael G. Sension, MD; Elly Fatehi, PharmD, MPH; and Jeffrey D. Dunn, PharmD, MBA, examine the potential for collaboration among payers and providers to achieve good clinical outcomes in HIV treatment that are cost effective.
HIV Therapy Utilization Management Concerns
March 19, 2018 – 
Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Michael G. Sension, MD; and Elly Fatehi, PharmD, MPH, offer insight regarding the potential impact that tighter management of HIV agents would have on clinical decision making.
Formulary Decision-Making Challenges in HIV
March 19, 2018 – 
Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Michael G. Sension, MD; and Elly Fatehi, PharmD, MPH, discuss the challenges with payer management of HIV therapies.
Balancing Cost and Physician Choice in HIV
March 12, 2018 – 
Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Michael G. Sension, MD; and Elly Fatehi, PharmD, MPH, discuss the difficulty in finding a common ground with clinical decision making and cost control for HIV therapies.
HIV Medication Adherence and Resistance Development
March 12, 2018 – 
Peter L. Salgo, MD; Elly Fatehi, PharmD, MPH; Jeffrey D. Dunn, PharmD, MBA; and Michael G. Sension, MD, discuss the connection between poor compliance and development of resistance in patients with HIV.
Nuances of HIV Treatment
March 05, 2018 – 
Peter L. Salgo, MD; Elly Fatehi, PharmD, BCPS; Michael Sension, MD; and Jeffrey Dunn, PharmD, explore scenarios that require HIV treatments that fall outside of the guideline recommendations for most patients.
HIV Treatment Initiation and Resistance Testing
March 05, 2018 – 
Peter L. Salgo, MD; Michael Sension, MD; Jeffrey Dunn, PharmD; and Elly Fatehi, PharmD, BCPS, offer their perspectives on the rationale for initiating HIV therapy and testing for resistance at diagnosis.
Population Management and Cost Containment in HIV
February 27, 2018 – 
Peter L. Salgo, MD; Michael Sension, MD; Jeffrey Dunn, PharmD; and Elly Fatehi, PharmD, BCPS, examine the prevalence of HIV and ways to control costs without compromising care.
Impact of HIV Guideline Changes on Payer Decisions
February 27, 2018 – 
Peter L. Salgo, MD; Michael Sension, MD; and Jeffrey Dunn, PharmD, discuss the need for more individualized therapy in HIV and the impact of guideline updates on payer decisions.
HIV Guideline Update
February 21, 2018 – 
Peter L. Salgo, MD; Michael Sension, MD; Jeffrey Dunn, PharmD; and Elly Fatehi, PharmD, MPH, review the updates to the HHS treatment guideline for most people with human immunodeficiency virus.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
×

Sign In

Not a member? Sign up now!